IVAC-RCC-001: A Personalized Neoantigen Vaccine as Add-on to Standard of Care Checkpoint Inhibitor in Advanced/Metastatic RCC Patients
Clinical trial NCT05641545 · TERMINATED
Trial details
- NCT number
- NCT05641545
- Sponsor
- SLK Kliniken Heilbronn GmbH
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2024-09-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.